Letizia Boninsegna
Overview
Explore the profile of Letizia Boninsegna including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
28
Citations
1105
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ciccio C, Dugo C, Cecchetto A, Doraku J, Dalla Chiara E, Boninsegna L, et al.
Circ Cardiovasc Imaging
. 2019 Oct;
12(10):e009682.
PMID: 31597469
No abstract available.
2.
Landoni L, Marchegiani G, Pollini T, Cingarlini S, DOnofrio M, Capelli P, et al.
Ann Surg
. 2017 Dec;
269(4):725-732.
PMID: 29189384
Objective: The objective of the present analysis is 2-fold: first, to define the evolution of time trends on the surgical approach to pancreatic neuroendocrine neoplasms (Pan-NENs); second, to perform a...
3.
Paiella S, Marchegiani G, Miotto M, Malpaga A, Impellizzeri H, Montagnini G, et al.
Neuroendocrinology
. 2017 Jun;
106(3):234-241.
PMID: 28586782
Introduction: Cystic pancreatic neuroendocrine tumors (CPanNETs) represent an uncommon variant of pancreatic neuroendocrine tumors (PanNETs). Due to their rarity, there is a lack of knowledge with regard to clinical features...
4.
Partelli S, Gaujoux S, Boninsegna L, Cherif R, Crippa S, Couvelard A, et al.
JAMA Surg
. 2013 Aug;
148(10):932-9.
PMID: 23986355
Importance: Nonfunctioning pancreatic neuroendocrine tumors (NF-PanNETs) are often indolent neoplasms without lymph node (LN) metastasis at diagnosis. Therefore, in patients with low risk of LN metastasis, the extent of surgery...
5.
Foti G, Boninsegna L, Falconi M, Mucelli R
Radiol Med
. 2013 Jun;
118(7):1082-101.
PMID: 23801403
Purpose: This study was done to compare the diagnostic accuracy of multidetector computed tomography (MDCT) and magnetic resonance imaging (MRI) in the preoperative assessment of nonfunctioning pancreatic endocrine tumours (NFPET)....
6.
Zerbi A, Capitanio V, Boninsegna L, Delle Fave G, Pasquali C, Rindi G, et al.
HPB (Oxford)
. 2013 Mar;
15(12):935-43.
PMID: 23472667
Background: Information on malignant pancreatic neuroendocrine neoplasms (pNENs) is mostly from retrospective studies in highly selected patients. The aim of this prospective, multicentre study was to assess treatment and outcomes...
7.
Lopez C, Falconi M, Waldmann J, Boninsegna L, Fendrich V, Goretzki P, et al.
Ann Surg
. 2012 May;
257(2):308-14.
PMID: 22580937
Objective: To evaluate the outcome of pancreaticoduodenectomy (PD) versus non-PD resections for the treatment of gastrinoma in multiple endocrine neoplasia type 1. Background: Gastrinoma in MEN1 is considered a rarely...
8.
Crippa S, Zerbi A, Boninsegna L, Capitanio V, Partelli S, Balzano G, et al.
Arch Surg
. 2012 Mar;
147(3):261-6.
PMID: 22430908
Objective: To analyze the characteristics and outcomes following enucleation and pancreatic resections of insulinomas. Design: Retrospective cohort study; prospective database. Settings: Academic, tertiary, and referral centers. Patients: Consecutive patients with...
9.
Panzuto F, Campana D, Fazio N, Brizzi M, Boninsegna L, Nori F, et al.
Neuroendocrinology
. 2011 Dec;
96(1):32-40.
PMID: 22205326
Background: Knowledge of clinical course in advanced jejunoileal neuroendocrine tumors (NETs) is poor. Aim: To investigate progression-free survival (PFS), overall survival (OS), and possible predictors for disease progression (DP) in...
10.
Boninsegna L, Panzuto F, Partelli S, Capelli P, Delle Fave G, Bettini R, et al.
Eur J Cancer
. 2011 Dec;
48(11):1608-15.
PMID: 22129889
Introduction: Malignant pancreatic neuroendocrine tumours (PNENs) are generally associated with a good prognosis after radical resection. In other pancreatic malignancies predictors of recurrence and the role of lymph node ratio...